rincon bio

Rincon Bio performs allogeneic and syngeneic xenograft studies. 

Allogeneic models entail the implantation of human cancer cells into a host animal, typically an immunocompromised mouse or rat.  Xenograft tumor models are effective tools for assessing in vivo efficacy of candidate cancer drugs.   

​

With syngeneic models, the tumor cell line is derived from the same species as the host animal.  Syngeneic models can thus test the efficacy of immuno-oncology agents as single therapies, or in combination with other anti-cancer drugs.  Rincon Bio performs syngeneic studies in mice.

​

Other options include custom xenograft study designs, fluorescent imaging, MTD studies, pre-clinical drug formulation, tumor collection, organ collection, histology, and pharmacodynamic studies (ELISA, Luminex, PCR, sequencing).